Drug
Inavolisib
Inavolisib: highest development phase Phase 2, developed by Roche. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Inavolisib NCT07287150 | Phase 2 | Metastatic Castration-Resistant Prostate Cancer |
| Inavolisib NCT04929223 | Phase 1 | Metastatic Colorectal Cancer |
Latest
No recent events.
Follow Inavolisib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.